The estimated Net Worth of Mark D. Angelino is at least $862 Тысяча dollars as of 15 January 2021. Mark Angelino owns over 7,500 units of Generation Bio Co stock worth over $861,654 and over the last 4 years Mark sold GBIO stock worth over $0.
Mark has made over 3 trades of the Generation Bio Co stock since 2020, according to the Form 4 filled with the SEC. Most recently Mark exercised 7,500 units of GBIO stock worth $34,425 on 15 January 2021.
The largest trade Mark's ever made was exercising 62,560 units of Generation Bio Co stock on 14 August 2020 worth over $37,536. On average, Mark trades about 18,840 units every 39 days since 2020. As of 15 January 2021 Mark still owns at least 353,137 units of Generation Bio Co stock.
You can see the complete history of Mark Angelino stock trades at the bottom of the page.
Mark's mailing address filed with the SEC is C/O GENERATION BIO CO., 301 BINNEY ST, , CAMBRIDGE, MA, 02142.
Over the last 4 years, insiders at Generation Bio Co have traded over $37,722,950 worth of Generation Bio Co stock and bought 4,282,125 units worth $70,408,633 . The most active insiders traders include Jason P Rhodes, Biomedical Innovation Maste... и Public Equities, L.P.Minne .... On average, Generation Bio Co executives and independent directors trade stock every 11 days with the average trade being worth of $116,471. The most recent stock trade was executed by Yalonda Howze on 15 July 2024, trading 3,347 units of GBIO stock currently worth $8,167.
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Generation Bio Co executives and other stock owners filed with the SEC include: